Development and Characterization of Soy Lecithin Liposome as Potential Drug Carrier Systems for Doxorubicin

被引:5
作者
Ahmed, Shaimaa A. [1 ]
Salama, Aida A. [1 ]
Gaber, Mohamed H. [2 ]
Ali, Said A. [2 ]
机构
[1] Al Azhar Univ, Fac Sci, Phys Dept, Biophys Branch, Cairo, Egypt
[2] Cairo Univ, Fac Sci, Biophys Dept, Giza, Egypt
关键词
Drug delivery; Drug carriers; Doxorubicin; Soya lecithin; Liposomes;
D O I
10.1007/s12247-023-09732-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose The phospholipids from plant origins play an important role in different techniques, especially in drug delivery applications. The purpose of this study is to investigate the effect of liposomes prepared from plant origin as a cheap source of lipids as drug carriers.Methods Soy lecithin liposomes (SLP) were prepared and loaded with doxorubicin (DOX) to use as a drug delivery system. DOX was used as the model drug and DOX/SLP was successfully combined. The characteristics of these liposomes, zeta potential, size distribution, drug encapsulation efficiency (EE%), drug release, Fourier transform infrared (FTIR), and transmission electron microscopy (TEM) were checked followed by in vitro study. The cytotoxicity study by using free DOX and DOX/SLP is done on Mcf-7, human breast cancer as a cell line.Results The optimal DOX/SLP formulation had a mean size of 342 nm, a negative zeta potential of -22.3 mV, the loaded DOX/SLP showed EE% (83.68%), and a drug release profile of 35 h, all are recorded. Cytotoxicity assay showed that the IC50 of DOX/SLP is smaller than that of free DOX.Conclusion These results give evidence of the efficacy of using drug carriers from plant origin combined with drugs to increase the effective therapies against cancer medically and economically.
引用
收藏
页码:1415 / 1426
页数:12
相关论文
共 35 条
  • [1] Agunbiade Tolulope A, 2019, Methodist Debakey Cardiovasc J, V15, P243, DOI 10.14797/mdcj-15-4-243
  • [2] Anticancer chemotherapy in teenagers and young adults: managing long term side effects
    Ahmad, Saif S.
    Reinius, Marika A. V.
    Hatcher, Helen M.
    Ajithkumar, Thankamma V.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 354 : i4567
  • [3] Cell-Based Assays for High-Throughput Screening
    An, W. Frank
    Tolliday, Nicola
    [J]. MOLECULAR BIOTECHNOLOGY, 2010, 45 (02) : 180 - 186
  • [4] Battaglia DP, 2013, NANOMATERIALS FOR MEDICAL APPLICATIONS, P181, DOI 10.1016/B978-0-12-385089-8.00005-4
  • [5] Structural alterations in rat liver proteins due to streptozotocin-induced diabetes and the recovery effect of selenium: Fourier transform infrared microspectroscopy and neural network study
    Bozkurt, Ozlem
    Bayari, Sevgi Haman
    Severcan, Mete
    Krafft, Christoph
    Popp, Juergen
    Severcan, Feride
    [J]. JOURNAL OF BIOMEDICAL OPTICS, 2012, 17 (07)
  • [6] Ehrlich tumor inhibition using doxorubicin containing liposomes
    Elbialy, Nihal Saad
    Mady, Mohsen Mahmoud
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (02) : 182 - 187
  • [7] Fesahat F., 2015, Trends Pharm Sci, V1, P20
  • [8] Size Determination of a Liposomal Drug by Small-Angle X-ray Scattering Using Continuous Contrast Variation
    Garcia-Diez, Raul
    Gollwitzer, Christian
    Krumrey, Michael
    Varga, Zoltan
    [J]. LANGMUIR, 2016, 32 (03) : 772 - 778
  • [9] A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin
    Gewirtz, DA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 57 (07) : 727 - 741
  • [10] Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity
    Gkionis, Leonidas
    Campbell, Richard A.
    Aojula, Harmesh
    Harris, Lynda K.
    Tirella, Annalisa
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 590